Mechanistically, oral IMQ activates pDC to produce IFN-I, which then exerts a profound impact on the tumor microenvironment (TME) by inducing TLR7/8 expression on DCs and macrophages in both mice and in patients. The gene discussed is TLR7; the disease is neoplasm.